Thousands Sue Weight Loss Drug Manufacturers With Serious Harm AllegationsBy Anthony Yates Thousands of people have come forward alleging serious harm caused by GLP-1 weight loss drugs. Those products include Ozempic, Wegovy, and Mounjaro. According to a report by USA Today, at least 4,400 people have filed lawsuits since the first was filed in 2023. Those suits are now part of a consolidated federal and state litigation and target two drugmakers: Novo Nordisk, which manufactures Ozempic, and Eli Lilly, which makes Trulicity, Mounjaro, and Zepbound. The companies reportedly said they refute the allegations and will defend the safety of their products. The USA Today report focuses on three troubling cases in the growing lawsuit. 63-year-old Todd Engel was using Ozempic to manage his diabetes. However, he told the outlet that he lost vision in one eye after using the drug for four months. His medication reportedly never came up as a potential cause of his sight loss, and he lost vision in his other eye months later. 72-year-old JoHelen McClain reportedly used Wegovy in November 2023, aiming to shed a few pounds. In March 2024, she heard a noise like a "balloon popping," which she later discovered was the sound of her colon rupturing. USA Today also interviewed Mark Smith. He told the outlet that his wife, 62-year-old Robin Smith, was taking Mounjaro for weight loss. She reportedly visited the hospital twice for vomiting. Her doctor suggested she stop using the drug, but her problems persisted. Days later, doctors diagnosed her with Wernicke's encephalopathy, which the outlet explains is a neurological condition caused by a lack of thiamine or Vitamin B1. It's often linked to malnutrition. The outlet points out that an estimated 12% of Americans use GLP-1 weight-loss drugs and that the plaintiff's account for a small percentage of users. USA Today also cites a 2024 court filing by the two drug companies. They explain that the known risks are reflected in FDA-approved labeling, which the FDA has reviewed more than 40 times. USA Today details a Gallup Study, which claims that the usage of GLP-1 drugs doubled between 2024 and 2025.Chief of Research and Development at the St. Louis Veterans Affairs Health Care System, Ziyad Al-Aly, reportedly stated that no medicine is risk-free. However, he believes the benefits outweigh the risks for most patients. Legal challenges are expected to take several years. ARTICLE SOURCE: https://screenrant.com/thousands-sue-weight-loss-drug-manufacturers/
This is a really great article until the last sentence, which makes an inaccurate statement for the sole purpose of dogging a low carb or keto diet. Just ignore that part, lol
------------------------------------------------------------
Intermittent fasting could boost immunity in addition to melting fat
By Grace Wade
Intermittent fasting has become all the rage in recent years because it promotes weight loss by depriving the body of glucose, which forces it to break down fat to produce an alternative fuel source called ketones. Intermittent fasting could also boost immunity and help combat disease, going by a finding in mice showing that immune cells more effectively fend off infections and cancer when using ketones as an energy source.
It is widely believed that cells prefer glucose for energy. However, Russell Jones at the Van Andel Institute in Michigan and his colleagues previously found that certain immune cells that combat pathogens, called T cells, don’t produce much energy using glucose.
“We said, 'well this is weird,'” says Jones. “These cells need lots of energy. So, what are they using to make [it]?”
He and his colleagues collected data from three other studies that genetically analysed T cells responding to infections and tumours. They found that, compared with dysfunctional T cells, effective T cells had increased activity in genes involved in breaking down ketones, indicating that they derived energy from ketones when fighting disease.
Next, the researchers genetically engineered three mice so that they couldn’t break down ketones and compared their response to an infection with an equal number of mice that could. They found that, on average, the normal mice had 50 per cent more T cells producing substances to kill off pathogens, called cytokines, than the engineered animals, and that these animals could churn out more cytokines per T cell as well. In other words, the ability to break down ketones made T cells more effective at fighting off infections in mice. Or, as Jones says, it increased the number of soldiers and ammunition on the front line.
Jones and his team also injected cancerous cells into the mice and found that after 22 days, tumours in the mice that were unable to break down ketones were twice the size of those in the mice that could.
Together, these findings suggest that immune cells are more effective at fighting disease when using ketones rather than glucose for fuel, says Jones.
They also explain why previous research has shown that fasting for 12 or more hours daily improves immune function in mice, says Satchidananda Panda at the Salk Institute for Biological Studies in California, who was not involved in the study.
Additionally, the results could help us understand how dietary interventions that boost ketone production, such as intermittent fasting, may affect our ability to fight off infections and cancer, says Jones. However, he cautions that not all ketone-producing diets have the same effects. For instance, the low-carbohydrate ketogenic diet may impair immunity as high levels of fat can suppress immune cells, he says.
Journal reference:
Immunity DOI: 10.1016/j.immuni.2023.07.002
ARTICLE SOURCE: https://www.msn.com/en-us/health/medical/intermittent-fasting-could-boost-immunity-in-addition-to-melting-fat/ar-AA1eukpJ
Subscribe to Carnivore Talk on YouTube | Be our guest on the channel | Leave me a voicemail, yo!